V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency — Stella

Home/Immunodeficiencies/

View on ClinicalTrials.gov

Recruiting

Back to Immunodeficiencies trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Brazil

IMIP Centro de Pesquisa, Recife, Pernanbuco

Key details

Phase

Large-scale testing

Sponsor

On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.

Collaborators

Hospital do Coracao

Enrollment target

~50 participants

Started

August 2025

Primary completion

September 2026

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

2 Years and older

Last updated January 2026